Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (SHA:603707)

China flag China · Delayed Price · Currency is CNY
9.44
+0.01 (0.11%)
Apr 29, 2026, 3:00 PM CST
-16.39%
Market Cap 15.25B
Revenue (ttm) 3.76B
Net Income (ttm) 649.83M
Shares Out 1.62B
EPS (ttm) 0.40
PE Ratio 23.49
Forward PE 14.98
Dividend 0.10 (1.06%)
Ex-Dividend Date Jun 5, 2025
Volume 8,911,702
Average Volume 10,869,668
Open 9.43
Previous Close 9.43
Day's Range 9.40 - 9.49
52-Week Range 9.00 - 12.27
Beta 0.62
RSI 44.64
Earnings Date Apr 30, 2026

About SHA:603707

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of drugs and APIs in China. It also provides heparin sodium, enoxaparin sodium, dalteparin sodium, nadroparin calcium, atracurium besylate, cisatracurium, calcium folinate, doxorubicin, milrinone, bleomycin, carboplatin, cytarabine, topotecan hydrochloride, phenylephrine hydrochloride, ganirelix acetate, furosemide, glycopyrrolate, neostigmine methylsulfate, succinylcholine chloride, reganosin, isoflurane blue, clofarabine, halo... [Read more]

Sector Healthcare
Founded 2000
Employees 1,360
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603707
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.